Literature DB >> 19276069

Structural basis for the antiproliferative activity of the Tob-hCaf1 complex.

Masataka Horiuchi1, Kosei Takeuchi, Nobuo Noda, Nobuyuki Muroya, Toru Suzuki, Takahisa Nakamura, Junko Kawamura-Tsuzuku, Kiyohiro Takahasi, Tadashi Yamamoto, Fuyuhiko Inagaki.   

Abstract

The Tob/BTG family is a group of antiproliferative proteins containing two highly homologous regions, Box A and Box B. These proteins all associate with CCR4-associated factor 1 (Caf1), which belongs to the ribonuclease D (RNase D) family of deadenylases and is a component of the CCR4-Not deadenylase complex. Here we determined the crystal structure of the complex of the N-terminal region of Tob and human Caf1 (hCaf1). Tob exhibited a novel fold, whereas hCaf1 most closely resembled the catalytic domain of yeast Pop2 and human poly(A)-specific ribonuclease. Interestingly, the association of hCaf1 was mediated by both Box A and Box B of Tob. Cell growth assays using both wild-type and mutant proteins revealed that deadenylase activity of Caf1 is not critical but complex formation is crucial to cell growth inhibition. Caf1 tethers Tob to the CCR4-Not deadenylase complex, and thereby Tob gathers several factors at its C-terminal region, such as poly(A)-binding proteins, to exert antiproliferative activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19276069      PMCID: PMC2676056          DOI: 10.1074/jbc.M809250200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Structure of Escherichia coli exonuclease I suggests how processivity is achieved.

Authors:  W A Breyer; B W Matthews
Journal:  Nat Struct Biol       Date:  2000-12

2.  Plat-E: an efficient and stable system for transient packaging of retroviruses.

Authors:  S Morita; T Kojima; T Kitamura
Journal:  Gene Ther       Date:  2000-06       Impact factor: 5.250

3.  Tob2, a novel anti-proliferative Tob/BTG1 family member, associates with a component of the CCR4 transcriptional regulatory complex capable of binding cyclin-dependent kinases.

Authors:  N Ikematsu; Y Yoshida; J Kawamura-Tsuzuku; M Ohsugi; M Onda; M Hirai; J Fujimoto; T Yamamoto
Journal:  Oncogene       Date:  1999-12-09       Impact factor: 9.867

4.  Structural basis for proofreading during replication of the Escherichia coli chromosome.

Authors:  Samir Hamdan; Paul D Carr; Susan E Brown; David L Ollis; Nicholas E Dixon
Journal:  Structure       Date:  2002-04       Impact factor: 5.006

5.  Antiproliferative proteins of the BTG/Tob family are degraded by the ubiquitin-proteasome system.

Authors:  Hitoshi Sasajima; Koji Nakagawa; Hideyoshi Yokosawa
Journal:  Eur J Biochem       Date:  2002-07

6.  Negative regulation of BMP/Smad signaling by Tob in osteoblasts.

Authors:  Y Yoshida; S Tanaka; H Umemori; O Minowa; M Usui; N Ikematsu; E Hosoda; T Imamura; J Kuno; T Yamashita; K Miyazono; M Noda; T Noda; T Yamamoto
Journal:  Cell       Date:  2000-12-22       Impact factor: 41.582

7.  The BTG2 protein is a general activator of mRNA deadenylation.

Authors:  Fabienne Mauxion; Céline Faux; Bertrand Séraphin
Journal:  EMBO J       Date:  2008-03-13       Impact factor: 11.598

8.  Mice lacking a transcriptional corepressor Tob are predisposed to cancer.

Authors:  Yutaka Yoshida; Takahisa Nakamura; Masato Komoda; Hitoshi Satoh; Toru Suzuki; Junko K Tsuzuku; Takashi Miyasaka; Eri H Yoshida; Hisashi Umemori; Reiko K Kunisaki; Kenzaburo Tani; Shunsuke Ishii; Shigeo Mori; Masami Suganuma; Tetsuo Noda; Tadashi Yamamoto
Journal:  Genes Dev       Date:  2003-05-15       Impact factor: 11.361

9.  Identification of the Anti-proliferative protein Tob as a MAPK substrate.

Authors:  Momoko Maekawa; Eisuke Nishida; Takuji Tanoue
Journal:  J Biol Chem       Date:  2002-07-31       Impact factor: 5.157

10.  Cloning of PC3B, a novel member of the PC3/BTG/TOB family of growth inhibitory genes, highly expressed in the olfactory epithelium.

Authors:  P Buanne; G Corrente; L Micheli; A Palena; P Lavia; C Spadafora; M K Lakshmana; A Rinaldi; S Banfi; M Quarto; A Bulfone; F Tirone
Journal:  Genomics       Date:  2000-09-15       Impact factor: 5.736

View more
  45 in total

Review 1.  The structural basis for deadenylation by the CCR4-NOT complex.

Authors:  Mark Bartlam; Tadashi Yamamoto
Journal:  Protein Cell       Date:  2010-06-04       Impact factor: 14.870

2.  Quantitative characterization of Tob interactions provides the thermodynamic basis for translation termination-coupled deadenylase regulation.

Authors:  Lin Ruan; Masanori Osawa; Nao Hosoda; Shunsuke Imai; Asako Machiyama; Toshiaki Katada; Shin-ichi Hoshino; Ichio Shimada
Journal:  J Biol Chem       Date:  2010-07-01       Impact factor: 5.157

3.  Homozygous Mutations in BTG4 Cause Zygotic Cleavage Failure and Female Infertility.

Authors:  Wei Zheng; Zhou Zhou; Qianqian Sha; Xiangli Niu; Xiaoxi Sun; Juanzi Shi; Lei Zhao; Shuoping Zhang; Jing Dai; Sufen Cai; Fei Meng; Liang Hu; Fei Gong; Xiaoran Li; Jing Fu; Rong Shi; Guangxiu Lu; Biaobang Chen; Hengyu Fan; Lei Wang; Ge Lin; Qing Sang
Journal:  Am J Hum Genet       Date:  2020-06-04       Impact factor: 11.025

4.  Structural basis of binding of P-body-associated proteins GW182 and ataxin-2 by the Mlle domain of poly(A)-binding protein.

Authors:  Guennadi Kozlov; Nozhat Safaee; Angelika Rosenauer; Kalle Gehring
Journal:  J Biol Chem       Date:  2010-02-24       Impact factor: 5.157

5.  Crystal structure and functional properties of the human CCR4-CAF1 deadenylase complex.

Authors:  Ying Chen; Elena Khazina; Elisa Izaurralde; Oliver Weichenrieder
Journal:  Nucleic Acids Res       Date:  2021-06-21       Impact factor: 16.971

6.  BTG2 inhibits the proliferation, invasion, and apoptosis of MDA-MB-231 triple-negative breast cancer cells.

Authors:  Yan-jun Zhang; Lichun Wei; Mei Liu; Jie Li; Yi-qiong Zheng; Ying Gao; Xi-ru Li
Journal:  Tumour Biol       Date:  2013-02-19

7.  Molecular basis of eRF3 recognition by the MLLE domain of poly(A)-binding protein.

Authors:  Guennadi Kozlov; Kalle Gehring
Journal:  PLoS One       Date:  2010-04-14       Impact factor: 3.240

8.  BTG4 is a meiotic cell cycle-coupled maternal-zygotic-transition licensing factor in oocytes.

Authors:  Chao Yu; Shu-Yan Ji; Qian-Qian Sha; Yujiao Dang; Jian-Jie Zhou; Yin-Li Zhang; Yang Liu; Zhong-Wei Wang; Boqiang Hu; Qing-Yuan Sun; Shao-Chen Sun; Fuchou Tang; Heng-Yu Fan
Journal:  Nat Struct Mol Biol       Date:  2016-04-11       Impact factor: 15.369

Review 9.  BTG/TOB factors impact deadenylases.

Authors:  Fabienne Mauxion; Chyi-Ying A Chen; Bertrand Séraphin; Ann-Bin Shyu
Journal:  Trends Biochem Sci       Date:  2009-10-12       Impact factor: 13.807

10.  BTG2 suppresses cancer cell migration through inhibition of Src-FAK signaling by downregulation of reactive oxygen species generation in mitochondria.

Authors:  Seo-Kyung Lim; Yong Won Choi; In Kyoung Lim; Tae Jun Park
Journal:  Clin Exp Metastasis       Date:  2012-05-06       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.